Our spinout companies
Circadian therapeutics
Circadian Therapeutics develops products that target serious diseases associated with circadian rhythm disruption.
Human-Centric Drug Discovery
Human-Centric Drug Discovery integrates clinical health record informatics, disease- and therapy-relevant human cellular assays and genomics to ensure that the nominated targets for drug discovery have robust validation.